Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | December 02, 2022 09:10am

Gainers

  • Anavex Life Sciences (NASDAQ:AVXL) stock moved upwards by 60.1% to $14.2 during Friday's pre-market session. The company's market cap stands at $1.1 billion. The company's, Q4 earnings came out 4 days ago.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) stock rose 30.82% to $0.9. The company's market cap stands at $154.6 million.
  • Revelation Biosciences (NASDAQ:REVBU) stock rose 24.94% to $0.3.
  • Lannett (NYSE:LCI) shares increased by 18.22% to $0.72. The market value of their outstanding shares is at $30.2 million.
  • Novan (NASDAQ:NOVN) shares moved upwards by 11.4% to $1.27. The company's market cap stands at $31.0 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 9.97% to $0.44. The market value of their outstanding shares is at $5.7 million.

Losers

  • Redhill Biopharma (NASDAQ:RDHL) stock declined by 17.8% to $0.3 during Friday's pre-market session. The market value of their outstanding shares is at $19.1 million. As per the press release, Q3 earnings came out 3 days ago.
  • Pliant Therapeutics (NASDAQ:PLRX) shares decreased by 15.36% to $15.05. The market value of their outstanding shares is at $733.8 million.
  • Immix Biopharma (NASDAQ:IMMX) stock decreased by 13.79% to $1.0. The company's market cap stands at $13.9 million.
  • Biophytis (NASDAQ:BPTS) stock declined by 13.3% to $0.43. The company's market cap stands at $8.8 million.
  • BIMI Intl Medical (NASDAQ:BIMI) stock decreased by 10.52% to $0.21. The market value of their outstanding shares is at $8.0 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock declined by 8.91% to $2.25. The company's market cap stands at $6.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVXL BIMI BPTS ENSC IMMX LCI NOVN PLRX RDHL REVBU RIGL RNAZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist